Xorel 20 mg (Tablet (Enteric Coated))

Unit Price: ৳ 4.00 (10 x 10: ৳ 400.00)
Strip Price: ৳ 40.00

Medicine Details

Title

  • Xorel Gastro-resistant Tablets

Categories

  • Medicine
  • Gastrointestinal
  • Pharmaceutical

Indications

  • Treatment of active duodenal ulcer
  • Treatment of active benign gastric ulcer
  • Treatment of erosive or ulcerative gastro-esophageal reflux disease (GERD)
  • Long-term management of gastro-esophageal reflux disease (GERD maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Treatment of Zollinger-Ellison Syndrome
  • Eradication of Helicobacter pylori in patients with peptic ulcer disease

Mode of Action

  • Suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase
  • Characterized as a gastric proton-pump inhibitor

Dosage

  • Recommended oral dose for active duodenal ulcer and active benign gastric ulcer is 20 mg once daily in the morning
  • Recommended oral dose for erosive or ulcerative gastro-esophageal reflux disease (GERD) is 20 mg once daily for four to eight weeks
  • Maintenance dose of 20 mg or 10 mg once daily for long-term management of gastro-esophageal reflux disease (GERD maintenance)
  • 10 mg once daily for symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • 5 mg once daily for pediatric patients 1-11 years of age (less than 15 kg)
  • 10 mg once daily for pediatric patients 1-11 years of age (15 kg or more)
  • Recommended adult starting dose for Zollinger-Ellison Syndrome is 60 mg once a day, titrated upwards to 120 mg/day based on individual patient needs
  • Combination therapy for H. pylori eradication: Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1g twice daily for 7 days

Administration

  • Should be taken in the morning, before eating
  • Tablets should not be chewed or crushed, but should be swallowed whole

Interactions

  • May interact with compounds whose absorption is pH dependent
  • Co-administration with ketoconazole or itraconazole may decrease antifungal plasma levels
  • No interaction with liquid antacids observed
  • PPIs, including rabeprazole, should not be co-administered with atazanavir

Contraindications

  • Hypersensitivity to the active substance or any excipients
  • Contra-indicated in pregnancy and during breastfeeding

Side Effects

  • Well-tolerated in both short-term and long-term studies
  • May cause headache, diarrhea, abdominal pain, vomiting, constipation, dry mouth, changes in appetite, muscle pain, drowsiness, dizziness

Pregnancy & Lactation

  • US FDA pregnancy category 'C'
  • No adequate and well-controlled studies in pregnant women
  • Likely to be excreted in human milk

Precautions & Warnings

  • Symptomatic response does not preclude the presence of gastric or esophageal malignancy
  • Patients on long-term treatment should be kept under regular surveillance
  • Proton pump inhibitors may modestly increase the risk of hip, wrist, and spine fracture
  • Risk of cross-hypersensitivity reactions with other proton pump inhibitors or substituted benzimidazoles
  • Reports of blood dyscrasias and hepatic enzyme abnormalities
  • Caution in patients with severe hepatic dysfunction
  • Co-administration with atazanavir not recommended
  • Possible increase in the risk of gastrointestinal infections
  • Risk of severe hypomagnesemia after prolonged treatment
  • Potential reduction in vitamin B12 absorption
  • Rare cases of subacute cutaneous lupus erythematosus associated with PPIs
  • Potential interference with laboratory tests, including increased Chromogranin A level

Use in Special Populations

  • No dosage adjustment necessary for patients with renal or hepatic impairment
  • Not recommended for use in children due to lack of data on safety and efficacy

Overdose Effects

  • Effects generally minimal, representative of the known adverse event profile and reversible without further medical intervention
  • No specific antidote known
  • Extensively protein bound and not dialysable
  • Treatment should be symptomatic and general supportive measures should be utilized

Therapeutic Class

  • Proton Pump Inhibitor

Storage Conditions

  • Keep below 30°C temperature, away from light & moisture
  • Keep out of the reach of children

Chemical Structure

  • Molecular Formula: C18H21N3O3S

Commonly Asked Questions

  • What is Xorel 20 mg Tablet?
  • What is Xorel 20 mg Tablet used for?
  • What are the side effects of Xorel 20 mg Tablet?
  • How should I take Xorel 20 mg Tablet?
  • Can I take Xorel 20 mg Tablet while pregnant or breastfeeding?
  • What should I do if I overdose on Xorel 20 mg Tablet?
  • How long should I take Xorel 20 mg Tablet?
  • Is there anything else I should know about Xorel 20 mg Tablet?
  • Does Xorel 20 mg Tablet cause bone problems?
  • Can I take Xorel 20 mg Tablet with vitamin D?
  • Quick Tips

Related Brands